A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 28, 2025

Primary Completion Date

February 27, 2027

Study Completion Date

August 23, 2027

Conditions
ObesityWeight Management
Interventions
DRUG

XW003 injection

Subcutaneous injection

DRUG

semaglutide injection

Subcutaneous injection

Trial Locations (1)

Unknown

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Hangzhou Sciwind Biosciences Co., Ltd.

INDUSTRY

NCT07073417 - A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH) | Biotech Hunter | Biotech Hunter